As of 4:00pm ET
| +0.40 / +0.40%|
The 9 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 135.00, with a high estimate of 164.00 and a low estimate of 108.00. The median estimate represents a +33.47% increase from the last price of 101.15.
The current consensus among 9 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.